Paper42588694
PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy.
Kolesarić N and 5 others. Cancers (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy. Papers, record 42588694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42588694
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29460925 | Clinical implications of PTEN loss in prostate cancer. | Nat Rev Urol | 2018 | https://conductscience.org/library/papers/29460925 | PubMed |
| 2 | 26005866 | Spatial genomic heterogeneity within localized, multifocal prostate cancer. | Nat Genet | 2015 | https://conductscience.org/library/papers/26005866 | PubMed |
| 3 | 15160339 | Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. | Cancer | 2004 | https://conductscience.org/library/papers/15160339 | PubMed |
| 4 | 33328650 | Genomic and phenotypic heterogeneity in prostate cancer. | Nat Rev Urol | 2021 | https://conductscience.org/library/papers/33328650 | PubMed |
| 5 | 26612463 | Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer. | Mod Pathol | 2016 | https://conductscience.org/library/papers/26612463 | PubMed |
| 6 | 23271767 | Temporal changes in the pathologic assessment of prostate cancer. | J Natl Cancer Inst Monogr | 2012 | https://conductscience.org/library/papers/23271767 | PubMed |
| 7 | 40940958 | Prognostic Significance of PTEN Loss in Prostate Cancer: A Meta-Analysis of Gleason Grade and Clinical Outcomes. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40940958 | PubMed |
| 8 | 27041927 | The evolving Gleason grading system. | Chin J Cancer Res | 2016 | https://conductscience.org/library/papers/27041927 | PubMed |
| 9 | 28063613 | Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naïve Men? | Eur Urol | 2017 | https://conductscience.org/library/papers/28063613 | PubMed |
| 10 | 27451135 | Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. | Eur Urol | 2017 | https://conductscience.org/library/papers/27451135 | PubMed |
| 11 | 32630372 | The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32630372 | PubMed |
| 12 | 27499772 | Correlation between Gleason Scores in Needle Biopsy and Corresponding Radical Prostatectomy Specimens: A Twelve-Year Review. | Iran J Pathol | 2016 | https://conductscience.org/library/papers/27499772 | PubMed |
| 13 | 30993208 | Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology. | NPJ Precis Oncol | 2019 | https://conductscience.org/library/papers/30993208 | PubMed |
| 14 | 27483464 | Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study. | PLoS Med | 2016 | https://conductscience.org/library/papers/27483464 | PubMed |
| 15 | 36840446 | The Rate of Phosphatase and Tensin (PTEN) Gene Expression Loss in Prostate Cancer and its Link to Tumor Upgrading. | Urol J | 2023 | https://conductscience.org/library/papers/36840446 | PubMed |
| 16 | 29393241 | The Heterogeneity of Prostate Cancer: A Practical Approach. | Pathobiology | 2018 | https://conductscience.org/library/papers/29393241 | PubMed |
| 17 | 25724568 | Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling. | Hum Pathol | 2015 | https://conductscience.org/library/papers/25724568 | PubMed |
| 18 | 39254403 | Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects. | Asian J Androl | 2024 | https://conductscience.org/library/papers/39254403 | PubMed |
| 19 | 29225123 | Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer. | Urology | 2018 | https://conductscience.org/library/papers/29225123 | PubMed |
| 20 | 24993522 | PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. | Mod Pathol | 2015 | https://conductscience.org/library/papers/24993522 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NPEPPS | 9520 | PubTator's text mining | https://conductscience.org/library/genes/9520 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42588694
GET https://conductscience.org/api/papers/v1/42588694/references?page=2